{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:32:19Z","timestamp":1760646739026},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>Summary Introduction: Oral corticosteroids (OCS) are a mainstay of treatment for asthma exacerbations, and short-term OCS courses were generally considered to be safe. Nevertheless, frequent short-term OCS courses could lead to hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Our study aimed at investigating the integrity of the HPA axis in children with persistent asthma or recurrent wheezing at the beginning of an inhaled corticosteroids (ICS) trial. Method: Morning basal cortisol was assessed just before the beginning of ICS, and 30, 60, and 90 days later, using Immulite\u00ae Siemens Medical Solutions Diagnostic chemiluminescent enzyme immunoassay (Los Angeles, USA; 2006). Results: In all, 140 children (0.3-15 years old) with persistent asthma or recurrent wheezing have been evaluated and 40% of them reported short-term OCS courses for up to 30 days before evaluation. Out of these, 12.5% had biochemical adrenal suppression but showed adrenal recovery during a three-month ICS trial treatment. No significant differences were observed among children with or without adrenal suppression, neither in the number of days free of OCS treatment before cortisol evaluation (p=0.29) nor in the last OCS course duration (p=0.20). The number of short-term OCS courses reported in the year preceding the cortisol evaluation was also not different (p=0.89). Conclusion: Short-term systemic courses of corticosteroids at conventional doses can put children at risk of HPA axis dysfunction. ICS treatment does not impair adrenal recovery from occurring. Health practitioners should be aware of the risk of a blunted cortisol response upon exposure to stress during the follow-up of patients with persistent asthma or recurrent wheezing.<\/jats:p>","DOI":"10.1590\/1806-9282.63.10.899","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T22:40:09Z","timestamp":1513464009000},"page":"899-903","source":"Crossref","is-referenced-by-count":9,"title":["Oral corticosteroids for asthma exacerbations might be associated with adrenal suppression: Are physicians aware of that?"],"prefix":"10.1590","volume":"63","author":[{"given":"Cristina B.","family":"Barra","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jussara F.","family":"Fontes","sequence":"additional","affiliation":[{"name":"UFMG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco T\u00falio G.","family":"Cintra","sequence":"additional","affiliation":[{"name":"UFMG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata C.","family":"Cruz","sequence":"additional","affiliation":[{"name":"UFMG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana\u00edna A. G.","family":"Rocha","sequence":"additional","affiliation":[{"name":"UFMG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00edla Cristina C.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"UFMG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivani Novato","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2223\/JPED.2129","article-title":"Impact of an asthma management program on hospitalizations and emergency department visits","volume":"87","author":"Fontes MJ","year":"2011","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0091-6749(86)90315-5","article-title":"Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma","volume":"77","author":"Zora JA","year":"1986","journal-title":"Allergy Clin Immunol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaip.2015.05.003","article-title":"Children and adults with frequent hospitalizations for asthma exacerbation, 2012-2013: a multicenter observational study","volume":"3","author":"Hasegawa K","year":"2015","journal-title":"J Allergy Clin Imunnol Pract"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1378\/chest.112.5.1248","article-title":"Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients","volume":"112","author":"Clark DJ","year":"1995","journal-title":"Chest"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/jc.2003-031165","article-title":"Early adrenocortical recovery after glucocorticoid therapy in children with leukemia","volume":"89","author":"Cunha CF","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods CP","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref7","series-title":"The Global Strategy for Asthma Management and Prevention Global Initiative for Asthma (GINA)","year":"2015"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos I","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000433-199103000-00006","article-title":"Adrenal atrophy at autopsy in two asthmatic children","volume":"12","author":"Busuttil A","year":"1991","journal-title":"Am J Forensic Med Pathol"},{"issue":"9203","key":"ref10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen C","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(03)00008-2","article-title":"Perioperative management of patients treated with glucocorticoids","volume":"32","author":"Axelrod L","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref12","first-page":"CD008727","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia","volume":"8","author":"Gordijn MS","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-8-1","article-title":"Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"8","author":"Schuetz P","year":"2008","journal-title":"BMC Pulm Med"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1651-2227.2010.01936.x","article-title":"Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases","volume":"99","author":"Huber BM","year":"2010","journal-title":"Acta Paediatr"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids: use systematic review and meta-analysis","volume":"100","author":"Broesen LH","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2500\/aap.2015.36.3863","article-title":"Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use","volume":"36","author":"Zazzali JL","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/thx.2005.052456","article-title":"Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study","volume":"61","author":"Mortimer KJ","year":"2006","journal-title":"Thorax"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13223-015-0075-z","article-title":"CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma","volume":"11","author":"Issa-El-Khoury K","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874306401408010059","article-title":"Systemic effects of inhaled corticosteroids: an overview","volume":"8","author":"Pandya D","year":"2014","journal-title":"Open Respir Med J"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom","volume":"87","author":"Todd GR","year":"2002","journal-title":"Arch Dis Child"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1183\/09031936.06.00071905","article-title":"The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children","volume":"27","author":"Priftis KN","year":"2006","journal-title":"Eur Respir J"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1515\/JPEM.2006.19.8.1015","article-title":"Evaluation of hypothalamic-pitutitary-adrenal axis suppression by low-dose (0 5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests is asthmatic children with inhaled corticosteroid","volume":"19","author":"Ozbek OY","year":"2006","journal-title":"J Pediatr Endocrinol Metabol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cen.12655","article-title":"Adrenal responses to a low-dose short synacthen test in children with asthma","volume":"82","author":"Hawcutt DB","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children","volume":"101","author":"Aljebab F","year":"2016","journal-title":"Arch Dis Child"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/thx.51.9.941","article-title":"Adrenal suppression with budesonide and fluticasone propionate given by large volume spacer to asthmatic children","volume":"51","author":"Clark DJ","year":"1996","journal-title":"Thorax"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1183\/09031936.93.01050433","article-title":"Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone","volume":"1","author":"Pedersen S","year":"1988","journal-title":"Eur Respir J"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/pch\/17.5.e34","article-title":"Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid","volume":"17","author":"Smith RW","year":"2012","journal-title":"Paediatr Child Health"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00431-015-2610-9","article-title":"Evidence of hypothalamic-adrenal-axis suppression during moderate-to-high-dose inhaled corticosteroid use","volume":"174","author":"Cavkaytar O","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1542\/peds.2012-1147","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children","volume":"130","author":"Z\u00f6llner EW","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tem.2007.10.005","article-title":"The hypothalamic-pituitary-adrenal axis in asthmatic children","volume":"19","author":"Priftis KN","year":"2008","journal-title":"Trends Endocrinol Metab"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v63n10\/0104-4230-ramb-63-10-0899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T23:57:23Z","timestamp":1693353443000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302017001000899&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0104-42302017001000899"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.63.10.899","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}